Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab

BACKGROUND: Systemic sclerosis (SSc) patients often need immunosuppressive medication (IS) for disease control. If SSc is progressive despite IS, autologous hematopoietic stem cell transplantation (aHSCT) is a treatment option for selected SSc patients. aHSCT is effective with good available evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gernert, Michael, Tony, Hans-Peter, Fröhlich, Matthias, Schwaneck, Eva Christina, Schmalzing, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801940/
https://www.ncbi.nlm.nih.gov/pubmed/35111167
http://dx.doi.org/10.3389/fimmu.2021.817893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801940/
https://www.ncbi.nlm.nih.gov/pubmed/35111167
http://dx.doi.org/10.3389/fimmu.2021.817893

Ejemplares similares